Literature DB >> 11841485

Genetic analysis of the interleukin-1 receptor antagonist and its homologue IL-1L1 in alopecia areata: strong severity association and possible gene interaction.

R Tazi-Ahnini1, A Cox, A J G McDonagh, M J H Nicklin, F S di Giovine, J M Timms, A G Messenger, P Dimitropoulou, G W Duff, M J Cork.   

Abstract

Alopecia areata is an inflammatory hair loss disease with a major genetic component. The presence of focal inflammatory lesions with perifollicular T-cell infiltrates reflects the importance of local cytokine production in the pathogenesis. In addition to its fundamental pro-inflammatory role, the interleukin-1 (IL-1) system has major effects on hair growth regulation in vitro, with the inhibitory actions of IL-1alpha and IL-1beta being opposed by the receptor antagonist IL-1ra. The novel interleukin-1 like molecule 1 (IL-1L1) which has greatest gene sequence homology with IL1RN, the gene encoding IL-1ra, is another potential IL-1 antagonist. In view of previous studies suggesting a significant role for IL1RN polymorphisms in the pathogenesis of autoimmune/inflammatory disease, we have analysed polymorphisms of IL-1ra (IL1RN+2018) and its homologue IL-1L1 (IL1L1+4734) in a case-control association study on 165 patients and a large number of matched controls. Homozygosity for the rare allele of IL1RN (IL1RN*2) was significantly associated with alopecia areata [odds ratio (OR) = 1.89, 95% CI (1.09, 3.28); P = 0.02], confirming our previous findings of significant association with the IL1RN variable number tandem repeat (VNTR). The results also revealed a novel association involving a polymorphism of the interleukin-1 receptor antagonist homologue IL1L1 at position + 4734, IL1RN+2018, and alopecia areata. The effect of a genotype combining three copies of the rare alleles at the IL1RN and IL1L1 loci conferred a more than additive increase in the risk of disease compared to IL1RN+2018 or IL1L1+4734 alone [OR 3.37 (1.60, 7.06); P = 0.002], suggesting possible synergy between the IL1RN and IL1L1 genes. This effect was stronger in patients with severe disease (alopecia totalis/universalis) [OR 4.62 (1.87, 11.40), P = 0.0022], and in those with early age at onset (< 20 years) [OR = 6.38 (2.64, 15.42), P = 0.0002]. Our results suggest that these polymorphisms within IL1RN and IL1L1 themselves or a gene in linkage disequilibrium with IL1RN and IL1L1 predispose to the more severe forms of alopecia areata.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11841485     DOI: 10.1046/j.1365-2370.2002.00271.x

Source DB:  PubMed          Journal:  Eur J Immunogenet        ISSN: 0960-7420


  12 in total

1.  Genomewide scan for linkage reveals evidence of several susceptibility loci for alopecia areata.

Authors:  Amalia Martinez-Mir; Abraham Zlotogorski; Derek Gordon; Lynn Petukhova; Jianhong Mo; T Conrad Gilliam; Douglas Londono; Chad Haynes; Jurg Ott; Maria Hordinsky; Krassimira Nanova; David Norris; Vera Price; Madeleine Duvic; Angela M Christiano
Journal:  Am J Hum Genet       Date:  2007-01-05       Impact factor: 11.025

Review 2.  Lymphocytes, neuropeptides, and genes involved in alopecia areata.

Authors:  Amos Gilhar; Ralf Paus; Richard S Kalish
Journal:  J Clin Invest       Date:  2007-08       Impact factor: 14.808

Review 3.  Autoinflammation: From monogenic syndromes to common skin diseases.

Authors:  Tien V Nguyen; Edward W Cowen; Kieron S Leslie
Journal:  J Am Acad Dermatol       Date:  2013-02-28       Impact factor: 11.527

4.  Notch4, a non-HLA gene in the MHC is strongly associated with the most severe form of alopecia areata.

Authors:  R Tazi-Ahnini; M J Cork; D Wengraf; A G Wilson; D J Gawkrodger; M P Birch; A G Messenger; A J G McDonagh
Journal:  Hum Genet       Date:  2003-02-14       Impact factor: 4.132

5.  The Immunogenetics of Alopecia areata.

Authors:  Fateme Rajabi; Fahimeh Abdollahimajd; Navid Jabalameli; Mansour Nassiri Kashani; Alireza Firooz
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

Review 6.  The current state of knowledge of the immune ecosystem in alopecia areata.

Authors:  Samuel J Connell; Ali Jabbari
Journal:  Autoimmun Rev       Date:  2022-02-10       Impact factor: 17.390

Review 7.  What causes alopecia areata?

Authors:  K J McElwee; A Gilhar; D J Tobin; Y Ramot; J P Sundberg; M Nakamura; M Bertolini; S Inui; Y Tokura; L E King; B Duque-Estrada; A Tosti; A Keren; S Itami; Y Shoenfeld; A Zlotogorski; R Paus
Journal:  Exp Dermatol       Date:  2013-09       Impact factor: 3.960

8.  Association between IL17A/IL17RA Gene Polymorphisms and Susceptibility to Alopecia Areata in the Korean Population.

Authors:  Bark-Lynn Lew; Hee-Ryung Cho; Sik Haw; Hwi-Jun Kim; Joo-Ho Chung; Woo-Young Sim
Journal:  Ann Dermatol       Date:  2012-02-02       Impact factor: 1.444

9.  Interleukin-1 gene cluster variants in hemodialysis patients with end stage renal disease: An association and meta-analysis.

Authors:  G Tripathi; D Rangaswamy; M Borkar; N Prasad; R K Sharma; S N Sankhwar; S Agrawal
Journal:  Indian J Nephrol       Date:  2015 Jan-Feb

10.  Exomic sequencing of immune-related genes reveals novel candidate variants associated with alopecia universalis.

Authors:  Seungbok Lee; Seung Hwan Paik; Hyun-Jin Kim; Hyeong Ho Ryu; Soeun Cha; Seong Jin Jo; Hee Chul Eun; Jeong-Sun Seo; Jong-Il Kim; Oh Sang Kwon
Journal:  PLoS One       Date:  2013-01-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.